Effects of neuropharmacological agents on in vitro formation of complexes between nucleic acids and proteins.
D000818:Animals; D001590:Benztropine / Q000494:pharmacology; D002417:Cattle; D002746:Chlorpromazine / Q000494:pharmacology; D003061:Codeine / Q000494:pharmacology; D004269:DNA, Bacterial; D003891:Desipramine / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D006657:Histones; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D009696:Nucleic Acids; D009966:Orphenadrine / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011485:Protein Binding; D011506:Proteins; D012329:RNA, Bacterial; D012335:RNA, Ribosomal; D012710:Serum Albumin, Bovine; D012967:Sodium Dodecyl Sulfate; D014282:Trihexyphenidyl / Q000494:pharmacology
D004269:DNA, Bacterial; D006657:Histones; D009696:Nucleic Acids; D011506:Proteins; D012329:RNA, Bacterial; D012335:RNA, Ribosomal; D001590:Benztropine; D012710:Serum Albumin, Bovine; D012967:Sodium Dodecyl Sulfate; D009388:Neostigmine; D010672:Phenytoin; D014282:Trihexyphenidyl; D009020:Morphine; D008238:Lysergic Acid Diethylamide; D009966:Orphenadrine; D003891:Desipramine; D002746:Chlorpromazine; D003061:Codeine